| Imaging biomarker roadmap for cancer studies JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169-186, 2017 | 1093 | 2017 |
| Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial D Athauda, K Maclagan, SS Skene, M Bajwa-Joseph, D Letchford, ... The Lancet 390 (10103), 1664-1675, 2017 | 720 | 2017 |
| Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDG I Kayani, JB Bomanji, A Groves, G Conway, S Gacinovic, T Win, J Dickson, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 538 | 2008 |
| Exenatide and the treatment of patients with Parkinson’s disease I Aviles-Olmos, J Dickson, Z Kefalopoulou, A Djamshidian, P Ell, ... The Journal of clinical investigation 123 (6), 2730-2736, 2013 | 483 | 2013 |
| Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies N Burgos, MJ Cardoso, K Thielemans, M Modat, S Pedemonte, J Dickson, ... IEEE transactions on medical imaging 33 (12), 2332-2341, 2014 | 420 | 2014 |
| Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs) SA Schneider, MJ Edwards, P Mir, C Cordivari, J Hooker, J Dickson, ... Movement disorders: official journal of the Movement Disorder Society 22 (15 …, 2007 | 297 | 2007 |
| Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson’s disease I Aviles-Olmos, J Dickson, Z Kefalopoulou, A Djamshidian, J Kahan, P Ell, ... Journal of Parkinson's disease 4 (3), 337-344, 2014 | 293 | 2014 |
| A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors I Kayani, BG Conry, AM Groves, T Win, J Dickson, M Caplin, JB Bomanji Journal of Nuclear Medicine 50 (12), 1927-1932, 2009 | 284 | 2009 |
| Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study P Schwingenschuh, D Ruge, MJ Edwards, C Terranova, P Katschnig, ... Movement disorders 25 (5), 560-569, 2010 | 269 | 2010 |
| European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods … A Varrone, JC Dickson, L Tossici-Bolt, T Sera, S Asenbaum, J Booij, ... European journal of nuclear medicine and molecular imaging 40, 213-227, 2013 | 243 | 2013 |
| Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an … CA Lane, J Barnes, JM Nicholas, CH Sudre, DM Cash, TD Parker, ... The Lancet Neurology 18 (10), 942-952, 2019 | 226 | 2019 |
| Quantification of Myocardial Blood Flow in Absolute Terms Using 82Rb PET Imaging: The RUBY-10 Study SV Nesterov, E Deshayes, R Sciagrà, L Settimo, JM Declerck, XB Pan, ... JACC: Cardiovascular Imaging 7 (11), 1119-1127, 2014 | 184 | 2014 |
| Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT AM Groves, T Win, NJ Screaton, M Berovic, R Endozo, H Booth, I Kayani, ... Journal of Nuclear Medicine 50 (4), 538-545, 2009 | 179 | 2009 |
| EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ... European journal of nuclear medicine and molecular imaging 47, 1885-1912, 2020 | 178 | 2020 |
| Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer I Kayani, N Avril, J Bomanji, S Chowdhury, A Rockall, A Sahdev, P Nathan, ... Clinical Cancer Research 17 (18), 6021-6028, 2011 | 141 | 2011 |
| Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies ND Papathanasiou, A Boutsiadis, J Dickson, JB Bomanji Parkinsonism & related disorders 18 (3), 225-229, 2012 | 131 | 2012 |
| The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery C Rathore, JC Dickson, R Teotónio, P Ell, JS Duncan Epilepsy research 108 (8), 1306-1314, 2014 | 126 | 2014 |
| Population-based blood screening for preclinical Alzheimer’s disease in a British birth cohort at age 70 A Keshavan, J Pannee, TK Karikari, JL Rodriguez, NJ Ashton, ... Brain 144 (2), 434-449, 2021 | 125 | 2021 |
| Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study E Barkus, PD Morrison, D Vuletic, JC Dickson, PJ Ell, LS Pilowsky, ... Journal of psychopharmacology 25 (11), 1462-1468, 2011 | 125 | 2011 |
| Study protocol: Insight 46–a neuroscience sub-study of the MRC National Survey of Health and Development CA Lane, TD Parker, DM Cash, K Macpherson, E Donnachie, ... BMC neurology 17, 1-25, 2017 | 100 | 2017 |
